Skip to main content
NOVOGENE CO., LTD. logo

NOVOGENE CO., LTD. — Investor Relations & Filings

Ticker · 688315 ISIN · CNE1000052X3 Shanghai Stock Exchange Professional, scientific and technical activities
Filings indexed 558 across all filing types
Latest filing 2022-08-21 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688315

About NOVOGENE CO., LTD.

https://www.novogene.com

Novogene Co., Ltd. is a global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company offers a comprehensive suite of services, including whole genome sequencing, transcriptomics, epigenomics, and metagenomics, alongside specialized solutions for single-cell analysis and clinical diagnostics. Utilizing advanced high-throughput sequencing platforms and proprietary bioinformatics pipelines, Novogene supports research across diverse fields such as human health, agriculture, and environmental science. The organization serves a broad client base encompassing academic institutions, pharmaceutical companies, and biotechnology firms. With a focus on data quality and technical expertise, Novogene facilitates large-scale genomic studies and precision medicine initiatives through its network of high-capacity laboratories and integrated data management systems.

Recent filings

Filing Released Lang Actions
北京诺禾致源科技股份有限公司2022年度向特定对象发行股票证券募集说明书(申报稿)
Capital/Financing Update Classification · 95% confidence The document is titled '北京诺禾致源科技股份有限公司 2022 年度向特定对象发行 A 股股票募集说明书(申报稿)' which translates to 'Beijing Novogene Technology Co., Ltd. 2022 Annual Private Placement A-Share Stock Offering Prospectus (Draft)'. It is a detailed prospectus for a specific stock issuance to particular investors, including sections on company background, business model, shareholder structure, risk factors, and legal statements. The document is lengthy (15,000 characters) and contains comprehensive information about the stock issuance, the company's operations, and the use of proceeds. This type of document is a capital raising disclosure related to a private placement of shares, which fits the category of Capital/Financing Update (CAP). It is not an annual report, earnings release, or regulatory filing, but a detailed fundraising document. Therefore, the correct classification is CAP with high confidence.
2022-08-21 Chinese
发行人及保荐机构关于北京诺禾致源科技股份有限公司向特定对象发行股票申请文件的审核问询函的回复报告
Capital/Financing Update Classification · 95% confidence The document is a detailed response report to an inquiry letter from the Shanghai Stock Exchange regarding a company's application for a specific share issuance to targeted investors. It discusses the company's fundraising project, including the use of raised funds, project details, business scope, capacity utilization, and operational capabilities. The content is focused on the company's capital raising activities and the specifics of the financing project, including investment plans and compliance with regulatory inquiries. The document is lengthy (15,000 characters) and contains substantive information about the financing and capital use, not just an announcement or a brief summary. Therefore, it fits the category of a Capital/Financing Update (CAP).
2022-08-21 Chinese
北京诺禾致源科技股份有限公司独立董事关于第三届董事会第四次会议的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors of Beijing Nuohua Zhiyuan Technology Co., Ltd. regarding the fourth meeting of the third board of directors. It discusses adjustments to the 2022 plan for a private placement of A shares, including the reduction of funds to be raised, revisions to the issuance proposal, feasibility analysis report, and related commitments. The document references compliance with company law, securities law, and registration management measures. It is a formal opinion on board meeting matters related to capital raising but does not contain financial statements or detailed financial data itself. The document length is 1872 characters, which is relatively short and primarily consists of opinions and approvals rather than the full capital raising plan or financial report. Therefore, it is best classified as a Board/Management Information (MANG) filing, as it relates to board meeting decisions and opinions on capital raising matters rather than the capital raising update itself or a full financial report.
2022-08-19 Chinese
北京诺禾致源科技股份有限公司关于向特定对象发行A股股票摊薄即期回报与填补措施及相关主体承诺(修订稿)的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from Beijing Nuohe Zhiyuan Technology Co., Ltd. regarding a specific issuance of A shares to particular investors. It includes detailed financial impact analysis on earnings per share, assumptions for the issuance, rationale and necessity for the issuance, use of proceeds, risk warnings, and commitments from the company's board and controlling shareholders regarding measures to mitigate dilution of immediate returns. The document references regulatory guidelines and policies related to capital market fundraising and investor protection. It is not a full annual or interim financial report, nor is it a simple announcement of a report publication. It is a comprehensive update on a capital raising activity, including financial projections and corporate commitments related to the issuance. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (9306 characters) and content depth support this classification with high confidence.
2022-08-19 Chinese
北京诺禾致源科技股份有限公司2022年向特定对象发行A股股票募集资金使用的可行性分析报告(修订稿)
Capital/Financing Update Classification · 95% confidence The document is titled as a "2022年度向特定对象发行A股股票募集资金使用的可行性分析报告(修订稿)" which translates to "2022 Feasibility Analysis Report on the Use of Funds Raised by Private Placement of A Shares." It details the company's plan to raise capital through a private placement of shares, specifying the amount to be raised, the intended use of the funds (new drug R&D, marketing network construction, and working capital), and the feasibility and necessity of these investments. The document extensively discusses the capital raising plan, investment projects, and their impact on the company's financial and operational status. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document is not an annual report, earnings release, or other report types but specifically focuses on the capital raising and use of proceeds. The document length is over 6,000 characters, indicating it is a full report rather than a brief announcement. Therefore, the appropriate classification is CAP with high confidence.
2022-08-19 Chinese
北京诺禾致源科技股份有限公司第三届监事会第四次会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement from the supervisory board of Beijing Nuohe Zhiyuan Technology Co., Ltd. regarding resolutions passed in their fourth meeting of the third supervisory board. The content focuses on adjustments to the company's 2022 plan for a targeted issuance of A-shares, including changes to the amount of funds to be raised, investment projects, and related proposals. It includes voting results and references to detailed announcements published on the Shanghai Stock Exchange website. The document is not a full financial report, earnings release, or management discussion but rather an official announcement of decisions related to capital raising and share issuance plans. Given the focus on adjustments to a share issuance plan and fundraising amounts, this fits best under the category of Capital/Financing Update (CAP). The document length is 3266 characters, which is substantive enough to be more than a simple report publication announcement. Therefore, the classification is CAP with high confidence.
2022-08-19 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.